SEC Form 3 · accession 0001209191-18-050466
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Repella
Director
Period of report
Sep 7, 2018
Accepted (ET)
Sep 11, 2018 · 4:17 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001689813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities beneficially owned | holding | — | — | — | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
Exhibit 24.1 - Power of Attorney